Drugs Archives - Page 19 of 65 - ��ϳԹ�� News

KHN’s ‘What the Health?’: Taking a Shot at Gun Control

The U.S. House passed a package of bills seeking to keep some guns out of the hands of children and teenagers, but its fate in the Senate remains a big question mark. Meanwhile, the Federal Trade Commission takes on drug and hospital prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Cori Uccello of the American Academy of Actuaries about the most recent report from Medicare’s trustees board.

June 9, 2022

A man in a dark suit and light pink tie wearing glasses speaks.

Lawmaker Takes on Insurance Companies and Gets Personal About His Health

State Sen. Scott Wiener opens up about a weeklong stint in the hospital last year and what it’s like to live with Crohn’s disease. The San Francisco Democrat is pushing a bill that would require insurance companies to cover certain medications while patients appeal denials.

By Samantha Young

June 9, 2022

A photo shows an advertisement for Plan B inside of a pharmacy. Text on the sign reads, "Here for you when you need us. Plan B One-Step."

Patients for Profit: How Private Equity Hijacked Health Care

Misinformation Clouds America’s Most Popular Emergency Contraception

At a moment when half of U.S. states stand poised to outlaw or sharply curtail abortion services, the nation’s most popular emergency contraception brand rests in the unlikely stewardship of two private equity firms.

By Sarah Varney

June 7, 2022

A photo illustration shows a vial of insulin and a syringe on top of the state of California, tinted yellow. The blue background is faintly textured with $100 bills.

California Wants to Slash Insulin Prices by Becoming a Drugmaker. Can It Succeed?

Gov. Gavin Newsom proposed spending $100 million to make insulin affordable to millions of people with diabetes under a new state generic drug label, CalRx. But state officials haven’t said how much the insulin will cost patients or how the state will deal with distribution and other challenges.

By Angela Hart

June 7, 2022

Letters to the Editor

Readers and Tweeters Go to the Mat on Abortion Rights and Perceived Wrongs

KHN gives readers a chance to comment on a recent batch of stories.

June 2, 2022

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

After years of failure, the Maryland company aims to attract the vaccine-hesitant with an alternative to mRNA shots. But will it find a market?

By Arthur Allen and Sarah Jane Tribble

May 26, 2022

Postcard From Minneapolis

Tribal Pharmacy Dispenses Free Meds and Fills Gaps for Native Americans in the City

The Mashkiki Waakaa’igan Pharmacy in downtown Minneapolis gives Native Americans an economical option for filling prescriptions while being sensitive to tribal traditions and expectations.

By Katherine Huggins and Julia Mueller

May 24, 2022

KHN On Air

Watch: Going Beyond the Script of ‘The G Word’ and How Government Responds to Disease (Or Not)

KHN Editor-in-Chief Elisabeth Rosenthal joins comedian Adam Conover to discuss his new Netflix series, “The G Word,” which examines the federal government's role in Americans' lives, and how it plays out in the covid era.

May 20, 2022

KHN On Air

Journalists Recap the Latest on the Supreme Court Leak, Mental Health Care, and Fentanyl Testing Strips

KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.

May 14, 2022

Podcast

KHN’s ‘What the Health?’: The Invisible Pandemic

Covid cases are again climbing, but you wouldn’t know it from the behavior of public health and elected officials, much less the general public, all of whom seem to want to put the pandemic in the rearview mirror. Meanwhile, the fallout over the leaked Supreme Court draft opinion on abortion continues even as the Senate fails — again — to muster the votes to write abortion rights into law. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Alice Miranda Ollstein of Politico, and Sandhya Raman of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.

May 12, 2022

COVID-19

Is Paxlovid, the Covid Pill, Reaching Those Who Most Need It? The Government Won’t Say

Many public health workers are unable to see how many doses of Pfizer’s antiviral treatment are shipped to their communities and cannot tell whether vulnerable residents are filling prescriptions as often as their wealthier neighbors.

By Hannah Recht

May 12, 2022

A closeup photo of Dr. Herring's gloved hands shows a syringe of Sublocade.

Can a Monthly Injection Be the Key to Curbing Addiction? These Experts Say Yes

In California, where overdose deaths are on the rise, physicians say administering anti-addiction medication as a monthly injection holds tremendous potential. So, why aren’t more patients getting it?

By Jenny Gold

May 6, 2022

Podcast

KHN’s ‘What the Health?’: Leaked Abortion Opinion Rocks Washington’s World

The unprecedented early leak of a Supreme Court draft opinion that would overturn the landmark abortion-rights ruling Roe v. Wade has heated the national abortion debate to boiling. Meanwhile, the FDA, after years of consideration, moves to ban menthol flavors in cigarettes and cigars. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Shefali Luthra of the 19th, and Jessie Hellmann of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN’s Paula Andalo, who wrote the latest KHN-NPR “Bill of the Month” episode about a family whose medical debt drove them to seek care south of the border.

May 5, 2022

As Overdoses Soar, More States Decriminalize Fentanyl Testing Strips

Georgia may soon join a growing list of states decriminalizing the use of fentanyl testing strips. Bans of the strips — on the books in about half of states, experts say — stem from laws criminalizing drug paraphernalia adopted decades ago. But the testing devices are now recommended to help prevent overdose deaths.

By Andy Miller

May 5, 2022

Medicare Surprise: Drug Plan Prices Touted During Open Enrollment Can Rise Within a Month

Even the savviest Medicare drug plan shoppers can get a shock when they fill prescriptions: That great deal on medications is no bargain after prices go up.

By Susan Jaffe

May 3, 2022

Nimisha Srikanth sits on the floor next to her bed. She is surrounded by boxes full of Plan B and condoms.

Emergency Contraception Marks a New Battle Line in Texas

In the shadow of Texas’ austere abortion regulations, grassroots organizers employ stealth tactics to help young women get emergency contraception.

By Sarah Varney

April 28, 2022

KHN On Air

Journalists Cover the Gamut, From Rising Insulin Costs to Delays in Autism Care for Children

KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.

April 23, 2022

KHN & PolitiFact HealthCheck

US Rep. Gaetz’s Diagnosis of What’s Driving Insulin Costs Misses the Root Cause

A diabetes diagnosis is not always related to a person’s weight or overall health, especially for those with Type 1 diabetes, who are dependent on insulin treatment for life.

By Victoria Knight and Colleen DeGuzman

April 22, 2022

A photo shows pills arranged in the shape of a dollar sign on a bright yellow surface.

Perspective

Is My Drug Copay Coupon a Form of Charity — Or a Bribe?

Drug copayment assistance is a form of profitable charity — and, yes, that’s an oxymoron. Amid skyrocketing drug prices, it's understandable that patients desperately need help affording medicine, especially when their health is on the line. But these programs create a mirage that perpetuates our health care system’s reckless spending.

By Elisabeth Rosenthal

April 21, 2022

An illustration in pencil. A medical-gloved hand holds an hour glass. Inside the hourglass, pills with question marks fall down to become pills with dollar signs. A finger points to the dollar-sign pills.

COVID-19

Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the Lab

The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for covid. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.

By Arthur Allen

April 19, 2022

��ϳԹ��

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Drugs